Heizmann Oleg, Viehl C T, Schmid R, Müller-Brand J, Müller B, Oertli D
Allgemeinchirurgische Klinik, Universitätsspital Basel, Spitalstr. 21, CH-4031 Basel, Switzerland.
Eur J Med Res. 2009 Jan 28;14(1):37-41. doi: 10.1186/2047-783x-14-1-37.
The former standard surgical treatment in patients with primary hyperparathyroidism (pHPT) has been bilateral cervical exploration. New localization techniques and the possibility of intraoperative measurement of intact parathormone (iPTH) permit a focused, minimally invasive parathyroidectomy (MIP). The introduction of MIP without complete neck exploration leads to the potential risk of missing thyroid pathology. The aim of the present study is to evaluate the value of MIP in respect to coexisting thyroid findings and their impact on preoperative workup for primary hyperparathyroidism.
This is a prospective study including 30 consecutive patients with pHPT (median age 65 years; 17 females, 13 males). In all patients preoperative localization was performed by ultrasonography and 99m Tc-MIBI scintigraphy- Intraoperative iPTH monitoring was routinely done.
Ten patients (33%) had a concurrent thyroid finding requiring additional thyroid surgery, and two patients (7%) with negative localization results underwent bilateral neck exploration. Therefore, MIP was attempted in 18 (60%) patients. The conversion rate to a four gland exploration was 6% (1/18). The sensitivities of 99m Tc-MIBI scanning and ultrasonography were 83.3% and 76.6%, respectively. The respective accuracy rates were 83.3% and 76.6%. Of note, the combination of the two modalities did not improve the sensitivity and accuracy in our patient population. During a median follow-up of 40 months, none of the patients developed persistent or recurrent hypocalcaemia, resulting in a 100% cure rate.
Coexisting thyroid pathology is relatively frequent in patients with pHPT in our region. Among patients having pHPT without any thyroid pathology, the adenoma localization is correct with either ultrasonography or 99m Tc-MIBI scintigraphy in the majority of cases. MIP with iPTH monitoring are highly successful in this group of patients and this operative technique should be the method of choice.
原发性甲状旁腺功能亢进症(pHPT)患者以前的标准外科治疗方法是双侧颈部探查。新的定位技术以及术中测量完整甲状旁腺激素(iPTH)的可能性使得可以进行有针对性的微创甲状旁腺切除术(MIP)。不进行完整颈部探查而引入MIP会导致遗漏甲状腺病变的潜在风险。本研究的目的是评估MIP对于共存甲状腺病变的价值及其对原发性甲状旁腺功能亢进症术前检查的影响。
这是一项前瞻性研究,纳入了30例连续的pHPT患者(中位年龄65岁;女性17例,男性13例)。所有患者术前均通过超声检查和99m锝-甲氧基异丁基异腈(99mTc-MIBI)闪烁扫描进行定位。术中常规进行iPTH监测。
10例患者(33%)同时存在需要额外甲状腺手术的甲状腺病变,2例定位结果为阴性的患者接受了双侧颈部探查。因此,18例(60%)患者尝试进行MIP。转为四腺探查的比例为6%(1/18)。99mTc-MIBI扫描和超声检查的敏感性分别为83.3%和76.6%。各自的准确率分别为83.3%和76.6%。值得注意的是,在我们的患者群体中,两种检查方式联合使用并未提高敏感性和准确率。在中位随访40个月期间,没有患者出现持续性或复发性低钙血症,治愈率为100%。
在我们地区,pHPT患者中并存甲状腺病变相对常见。在没有任何甲状腺病变的pHPT患者中,大多数情况下通过超声检查或99mTc-MIBI闪烁扫描腺瘤定位是正确的。在这组患者中,采用iPTH监测的MIP非常成功,这种手术技术应成为首选方法。